$1.75
0.05[2.94%]
At close: Apr 26
$1.75
0[0.00%]
After Hours: 4:11PM EDT
Xeris Biopharma Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Xeris Biopharma Holdings using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | XERS | Q1 | -$0.12 | -$0.12 | — | — | $33.20M | $41.81M | — | — | Get Alert |
03/06/2024 | AM | XERS | Q4 | -$0.10 | -$0.10 | -$0.10 | 0.00% | $33.14M | $43.55M | $44.39M | 1.93% | Get Alert |
11/09/2023 | AM | XERS | Q3 | -$0.16 | -$0.12 | -$0.09 | 25.00% | $29.73M | $41.08M | $48.32M | 17.62% | Get Alert |
08/08/2023 | AM | XERS | Q2 | -$0.19 | -$0.13 | -$0.14 | -7.69% | $25.26M | $34.84M | $36.89M | 5.89% | Get Alert |
05/09/2023 | AM | XERS | Q1 | -$0.25 | -$0.17 | -$0.12 | 29.41% | $22.07M | $30.76M | $33.20M | 7.92% | Get Alert |
03/08/2023 | AM | XERS | Q4 | -$0.42 | -$0.16 | -$0.10 | 37.50% | $21.43M | $31.04M | $33.14M | 6.78% | Get Alert |
11/09/2022 | AM | XERS | Q3 | -$0.39 | -$0.16 | -$0.16 | 0.00% | $11.04M | $29.12M | $29.73M | 2.08% | Get Alert |
08/10/2022 | AM | XERS | Q2 | -$0.41 | -$0.20 | -$0.19 | 5.00% | $8.84M | $25.53M | $25.26M | -1.06% | Get Alert |
05/11/2022 | AM | XERS | Q1 | -$0.30 | -$0.25 | -$0.25 | 0.00% | $8.05M | $23.59M | $21.91M | -7.12% | Get Alert |
03/10/2022 | AM | XERS | Q4 | -$0.41 | -$0.24 | -$0.42 | -75.00% | $7.09M | $18.90M | $21.43M | 13.38% | Get Alert |
11/10/2021 | AM | XERS | Q3 | -$0.35 | -$0.37 | -$0.39 | -5.41% | $9.45M | $11.03M | $11.04M | 0.05% | Get Alert |
08/05/2021 | AM | XERS | Q2 | -$0.63 | -$0.30 | -$0.41 | -36.67% | $2.03M | $9.54M | $8.84M | -7.39% | Get Alert |
05/13/2021 | AM | XERS | Q1 | -$0.89 | -$0.34 | -$0.30 | 11.76% | $1.79M | $7.47M | $8.05M | 7.78% | Get Alert |
03/09/2021 | AM | XERS | Q4 | -$1.23 | -$0.38 | -$0.41 | -7.89% | $1.86M | $8.21M | $7.09M | -13.65% | Get Alert |
11/09/2020 | AM | XERS | Q3 | -$1.22 | -$0.52 | -$0.35 | 32.69% | $314.00K | $4.48M | $9.45M | 110.89% | Get Alert |
08/10/2020 | AM | XERS | Q2 | -$1.28 | -$0.73 | -$0.63 | 13.70% | $320.00K | $1.86M | $2.03M | 8.98% | Get Alert |
05/07/2020 | AM | XERS | Q1 | -$1.07 | -$0.89 | -$0.89 | 0.00% | $248.00K | $1.43M | $1.79M | 25.03% | Get Alert |
03/11/2020 | AM | XERS | Q4 | -$0.98 | -$1.13 | -$1.23 | -8.85% | $801.00K | $660.00K | $1.86M | 182.42% | Get Alert |
11/07/2019 | AM | XERS | Q3 | -$0.71 | — | -$1.22 | — | $582.00K | — | $314.00K | — | Get Alert |
Xeris Biopharma Holdings (XERS) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
The Actual EPS was $-0.10, which hit the estimate of $-0.10.
The Actual Revenue was $44.4M, which beat the estimate of $43.5M.
Browse earnings estimates, EPS, and revenue on all stocks.